| 发明名称 |
IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANT |
| 摘要 |
<p>The invention relates to the discovery that administration of NY-ESO-1 protein, in combination with a saponin based adjuvant leads to an unexpectedly strong immune response against NY-ESO-1 expressing cells. Preferably, the combination is administered intramuscularly.</p> |
| 申请公布号 |
EP1684800(A4) |
申请公布日期 |
2007.05.23 |
| 申请号 |
EP20040789341 |
申请日期 |
2004.09.30 |
| 申请人 |
LUDWIG INSTITUTE FOR CANCER RESEARCH;CSL LIMITED |
发明人 |
CEBON, JONATHAN;DAVIS, IAN;CHEN, WEISAN;GREEN, SIMON |
| 分类号 |
A61K39/385;A61K;A61K39/00;C12N |
主分类号 |
A61K39/385 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
